In acute lymphoblastic leukemia, KRAS (Kirsten rat sarcoma viral oncogene homolog) G12D mutation is responsible for the binding of cAMP response element binding (CREB) on IL1B promoter and increases the expression of IL-1β in these cells [107]. The gene discussed is KRAS; the disease is acute lymphoblastic leukemia.